1.
Alteration of Panel-Reactive Antibodies Following Treatment With Either Atorvastatin or Low-Dose Mycophenolate Mofetil in Sensitized Hemodialysis Patients. IJKD [Internet]. 2011 Aug. 29 [cited 2024 Jun. 18];5(5):342-6. Available from: https://www.ijkd.org/index.php/ijkd/article/view/364